PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31754392-15	2019	PET imaging in syngeneic tumor models revealed a varying maximum tumor-to-heart ratio of 89Zr-DFO-CD4 and 89Zr-DFO-CD8a across tumor types and in-between subjects that correlated with individual response to Sym021 at day 10 relative to start of therapy (p=0.0002 and p=0.0354, respectively).	Deferoxamine	94-97	CD4 antigen	Mus musculus	98-101	
9180188-5	1997	Treatment of iron-overloaded mice with the iron chelator, deferoxamine, resulted in the cure of mice from infection, restored the antifungal effector and immunomodulatory functions of the phagocytic cells, and allowed the occurrence of CD4 Th1 protective antifungal responses.	Deferoxamine	58-70	CD4 antigen	Mus musculus	236-239	
9180188-6	1997	These data indicate that iron overload may negatively affect CD4 Th1 development in mice with candidiasis, a function efficiently restored by therapy with deferoxamine.	Deferoxamine	155-167	CD4 antigen	Mus musculus	61-64	
31754392-16	2019	The maximum 89Zr-DFO-CD4 tumor-to-heart ratio could be used to stratify mice according to Sym021 therapy response and overall survival was improved in mice with a 89Zr-DFO-CD4 ratio >9 (p=0.0018).	Deferoxamine	17-20	CD4 antigen	Mus musculus	21-24	
31754392-16	2019	The maximum 89Zr-DFO-CD4 tumor-to-heart ratio could be used to stratify mice according to Sym021 therapy response and overall survival was improved in mice with a 89Zr-DFO-CD4 ratio >9 (p=0.0018).	Deferoxamine	17-20	CD4 antigen	Mus musculus	172-175	
31754392-16	2019	The maximum 89Zr-DFO-CD4 tumor-to-heart ratio could be used to stratify mice according to Sym021 therapy response and overall survival was improved in mice with a 89Zr-DFO-CD4 ratio >9 (p=0.0018).	Deferoxamine	168-171	CD4 antigen	Mus musculus	21-24	
31754392-16	2019	The maximum 89Zr-DFO-CD4 tumor-to-heart ratio could be used to stratify mice according to Sym021 therapy response and overall survival was improved in mice with a 89Zr-DFO-CD4 ratio >9 (p=0.0018).	Deferoxamine	168-171	CD4 antigen	Mus musculus	172-175